| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 07/08/2008 | US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases |
| 07/08/2008 | US7396523 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof |
| 07/08/2008 | CA2430488C Detection of microbial metabolites |
| 07/08/2008 | CA2368775C Treatment of cardiovascular and related pathologies |
| 07/03/2008 | WO2008078965A1 Ceramide derivatives, method for preparing the same, and therapeutic agent for treating atopic dermatitis comprising the ceramide derivatives |
| 07/03/2008 | WO2008078102A2 Lipids and their use as non-viral delivery vehicle |
| 07/03/2008 | WO2008078013A2 Fire proofing agent containing phosphinic acid or a salt thereof |
| 07/03/2008 | WO2008077911A1 Ligands and catalyst systems for the oligomerization of olefinic monomers |
| 07/03/2008 | WO2008077908A1 Ligands and catalyst systems thereof for the catalytic oligomerization of olefinic monomers |
| 07/03/2008 | WO2008077600A1 Compounds and methods for synthesis and purification of oligonucleotides |
| 07/03/2008 | WO2008077241A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
| 07/03/2008 | WO2007147222A3 Novel ionic liquids |
| 07/03/2008 | WO2007107276A3 Process for preparing c7 intermediates and their use in the preparation of n-substituted pyrrole derivatives |
| 07/03/2008 | US20080161592 Protein tyrosine phosphatase inhibitors and methods of use thereof |
| 07/03/2008 | US20080161565 Coupling [4-(1,3,4-oxadiazol-2-yl)phenyl]boronic acid with N-(Isobutoxycarbonyl) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl) Pyridine-3-sulphonamide, producing N-(isobutoxycarbonyl) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide |
| 07/03/2008 | US20080161272 Ceramide derivatives, method for preparing the same, and therapeutic agent for treating atopic dermatitis comprising the ceramide derivatives |
| 07/03/2008 | US20080161267 Mitoquinone Derivatives Used as Mitochondrially Targeted Antioxidants |
| 07/03/2008 | DE4408500B4 Phosporverbindungen enthaltende polyolefinische Zusammensetzungen Phosphorus compounds containing polyolefin compositions |
| 07/03/2008 | CA2673678A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
| 07/03/2008 | CA2673622A1 Lipid |
| 07/03/2008 | CA2673190A1 Ligands and catalyst systems for the oligomerization of olefinic monomers |
| 07/03/2008 | CA2673186A1 Ligands and catalyst systems thereof for the catalytic oligomerization of olefinic monomers |
| 07/03/2008 | CA2672727A1 Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| 07/03/2008 | CA2664118A1 Protease inhibitors |
| 07/02/2008 | EP1937699A2 Hypophosphorous acid derivatives and their therapeutical applications |
| 07/02/2008 | EP1937698A1 Stabilization of polyolefins with liquid cyclic phosphites |
| 07/02/2008 | EP1937669A1 Novel benzopyran derivatives as potassium channel openers |
| 07/02/2008 | EP1937277A1 Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose |
| 07/02/2008 | EP1692127B1 Triphenylethylene compounds as selective estrogen receptor modulators |
| 07/02/2008 | EP1640411B1 Reactive flame retardants and flame-retarded resin products |
| 07/02/2008 | EP1581323A4 Process for catalyst recovery from hydrocyanation product mixtures |
| 07/02/2008 | EP1328610B1 Phosphate fluorosurfactants for use in carbon dioxide |
| 07/02/2008 | CN101213199A Compounds for preparing immunological adjuvant |
| 07/02/2008 | CN101210031A Method for producing triphenylphosphine |
| 07/02/2008 | CN101210030A Method for preparing oligomerization phosphoric acid ester or oligomerization phosphorous acid ester |
| 07/02/2008 | CN100398549C Organic phosphate fiber crystal and its preparation method |
| 07/02/2008 | CN100398544C Aqueous triptolide alcohol derivative with high immunesuppressive activity and its application |
| 07/01/2008 | US7393980 Use of a composition of an ionic nature as a substrate reagent, a composition constituting a fluorination reagent and a method using same |
| 06/26/2008 | WO2008076417A1 (1r,6s)-2-azabicyclo[4.3.0] nonane-8,8-diphosphonic acid and its use in treating or preventing bone disorders, for example, osteoporosis or paget's disease |
| 06/26/2008 | WO2008076269A2 MONOPHOSPHATES AS MUTUAL PRODRUGS OF MUSCARINIC RECEPTOR ANTAGONISTS AND β-AGONISTS FOR THE TREATMENT OF COPD AND CHRONIC BRONCHITIS |
| 06/26/2008 | WO2008076265A1 MONOPHOSPHATES AS MUTUAL PRODRUGS OF ANTI-INFLAMMATORY SIGNAL TRANSDUCTION MODULATORS (AISTM'S) AND β-AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION |
| 06/26/2008 | WO2008075831A1 Process for preparing sodium risedronate hemipentahydrate |
| 06/26/2008 | WO2008075601A1 Phosphonium salt, catalyst for polymerization of alkylene oxide compound, and process for production of poly(alkylene oxide) |
| 06/26/2008 | WO2008075048A2 Polyalkyloxydibenz ( c, e) oxepine derivatives as medicaments |
| 06/26/2008 | WO2008074573A1 Topical dosage form comprising tri-substituted glycerol compounds |
| 06/26/2008 | WO2008074154A1 Polymers comprising zwitterionic endgroups |
| 06/26/2008 | US20080153950 Phosphorus-sulfur FR additives and polymer systems containing same |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 06/26/2008 | US20080153801 Benzoxazepine compounds, their production and use |
| 06/26/2008 | US20080153783 Pyrimidyl Phosphonate Antiviral Compounds and Methods of Use |
| 06/26/2008 | US20080149888 hydrogenated ionic compound; ammonium, phosphonium, or sulfonium cations; greater environmental compatibility and substantial safety advantages |
| 06/26/2008 | CA2673591A1 Chemical compounds |
| 06/26/2008 | CA2672191A1 (1r,6s)-2-azabicyclo[4.3.0] nonane-8,8-diphosphonic acid and its use in treating or preventing bone disorders, for example, osteoporosis or paget's disease |
| 06/26/2008 | CA2670730A1 Monophosphates as mutual prodrugs of anti-inflammatory signal transduction modulators (aistm's) and beta-agonists for the treatment of pulmonary inflammation and bronchoconstriction |
| 06/25/2008 | EP1935896A1 Novel optically active biaryl phosphorus compound and production process thereof |
| 06/25/2008 | EP1935895A1 Salts made from asymmetric substituted Bis-(1-Hydroxymethyl-)phosphine acids |
| 06/25/2008 | EP1935894A1 Carboxyethyl(alkyl)phosphine acid alkyl ester sulphates |
| 06/25/2008 | EP1934192A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 06/25/2008 | EP1933848A2 Phosphoantigen salts of organic bases and methods for their crystallization |
| 06/25/2008 | EP1853614A4 Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans |
| 06/25/2008 | EP1756128A4 Phosphonium salts derivatives and their use as solubility controlling auxiliaries |
| 06/25/2008 | EP1572360B1 Monocyclopentadienyl complexes |
| 06/25/2008 | EP1430147A4 Fluorescent quenching detection reagents and methods |
| 06/25/2008 | EP0942915B1 Pharmaceutical formulations |
| 06/25/2008 | CN101208349A Thiophene compound having phosphoric ester and process for producing the same |
| 06/25/2008 | CN101208348A Altering the crystal size distribution of N-(phosphonomethyl) iminodiacetic acid for improved filtration and product quality |
| 06/25/2008 | CN101205241A Calcium phosphocreatine and chemosynthesis method thereof |
| 06/25/2008 | CN101205240A Magnesium phosphocreatine and chemosynthesis method thereof |
| 06/25/2008 | CN101205239A Kalium phosphocreatine and chemosynthesis method thereof |
| 06/25/2008 | CN101205238A Extraction method of phytic acid in rice bran |
| 06/25/2008 | CN101205237A Extraction of high-purity lecithin from animal livers |
| 06/25/2008 | CN101205236A Pyridinedicarboxylic acid vanadyl complexes as well as agent, tablet, capsule and uses thereof |
| 06/25/2008 | CN100396785C Resoldution method for racemic compound of nucleoside enantiomorph |
| 06/25/2008 | CN100396763C Method for extracting lipid mixture containing phospholipids comprising polyunsaturated fatty acids from viscera of fish |
| 06/25/2008 | CN100396689C Tenoforv monoester compounds with HIV-1/HBV virus copying inhibiting activity |
| 06/25/2008 | CN100396688C Cephems phosphate and preparation process and use thereof |
| 06/25/2008 | CN100396675C Prodrugs of proton pump inhibitors |
| 06/25/2008 | CN100396670C N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors, its pharmaceutical composition and use |
| 06/24/2008 | US7390931 epimerizing monophospholanes and bisphospholanes by oxygen-free heating at a temperature greater or equal to 100 degree and less than or about equal to decomposition temperature of mono ro bisphospholanes; can be used as catalyst in asymmetric synthesis of valuable drugs including pregabalin. |
| 06/24/2008 | US7390920 Oxidation catalyst and process |
| 06/24/2008 | US7390810 Pyrazole-amine compounds useful as kinase inhibitors |
| 06/24/2008 | US7390791 Prodrugs of phosphonate nucleotide analogues |
| 06/24/2008 | US7390780 For transfecting nucleic acids in vivo or ex vivo; vesicle forming lipid and hydrophilic polymer; gene therapy |
| 06/24/2008 | US7390703 Method for through-plating field effect transistors with a self-assembled monolayer of an organic compound as gate dielectric |
| 06/24/2008 | US7390672 Each spot comprises 3-hydroxypicolinic acid matrix and no analyte, andhas an amount of the matrix resulting from deposition of a reproduced, defined and controlled nanoliter volume of a solution comprising the matrix and an evaporating solvent; diagnosis |
| 06/19/2008 | WO2008073872A1 Organophosphonate oligomers, mixtures thereof, and processes for producing organophosphonate oligomers and mixtures thereof |
| 06/19/2008 | WO2008073871A1 Organophosphonate oligomers and mixtures thereof useful as flame retardants |
| 06/19/2008 | WO2008071738A1 Selective inhibitors of neurotensin degrading enzymes |
| 06/19/2008 | WO2008071719A1 Flame-resistant polyamide and process for producing it |
| 06/19/2008 | WO2008071692A2 Phosphonate compounds |
| 06/19/2008 | WO2008071691A2 Reactive phosphonates |
| 06/19/2008 | WO2008071689A2 Process for the manufacture of alkylamino alkylene phosphonic acids |
| 06/19/2008 | WO2008071508A1 Bisphosphite ligands for hydroformylation catalyzed by transition metals |
| 06/19/2008 | WO2008070960A1 Ibandronate sodium propylene glycol solvate and processes for the preparation thereof |
| 06/19/2008 | WO2008070947A2 Solid and water-soluble active ingredient and herbicide formulation, production process therefor, and process for controlling weeds |
| 06/19/2008 | WO2008054625A3 Anti-friction and anti-wear lubricant additives |
| 06/19/2008 | US20080146850 Method for Producing Tertiary Phosphines |
| 06/19/2008 | US20080146837 Method for Producing L-2-Amino-4-(Hydroxymethylphosphinyl)-Butanoic Acid |
| 06/19/2008 | US20080146836 New Aminopropylphosphinic acids |